Macrocyclic serine protease inhibitors
US9284307B2 · kind B2 · utility
0Cited by
66References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2010 |
| Grant date | Mar 15, 2016 |
| Priority date | — |
| Expiry date | Sep 6, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.